New Vaccines

Vaccinia

2009-10-12T07:29:00.000-07:00

Vaccinia, the cowpox virus, is closely related to the variola, or smallpox, viru. The term vaccine derives from vaccinia, because in the 18th century the English physician Edward Jennes used the vaccinia virus to develop the first successful preventive treatment for a communicable disease, smallpox, the treatment made possible the subsequent eradication of that disease.

Vaccinia is currently of special interest in genetic engineering for several reasons. Adverse reactions to the virus are rare and well understood, so it is considered safe; it is more easily transportable than most viruses, because it can be freeze dried and remain effective: Its administration is simple; and it is a large virus, making possible the use of recombinant-DNA techniques to create new vaccines. That is, genes from another virus can be spliced into vaccinia, creating a hybrid vaccine effective against both viruses.

See other articles:

Bird Flu Vaccine

2009-08-20T23:45:00.000-07:00

Influenza that came from avian is called as Avian Flu or Bird Flu still seen as having the potential to infect the entire human species. This bird flu is caused by H5N1 virus. This virus can mutate and become contagious and spread from one human to another. This will create a global pandemic and since we are not prepared to deal with it, it is a matter of concern for us all.

Until now, there is no known cure for the bird flu virus and that means that everyone is under constant threat. More recently, there have been some discussions on the use of annual flu vaccines. Scientists are worried that this constant exposure to the flu vaccine is weakening the natural human immune system to ward off infections and thereby putting everyone at greater risk of getting flu. Actually human have resist to this viruses last time, but because of the immune system become weak and the virus become strong then human become infect by this viruses.

A strong immune system is the best defense against all forms of infections and leading doctors are clear on the fact that someone who has not got a weaker immune system because of annual vaccination stands a better chance of avoiding the flu naturally. Some doctors even say that the practice of annual vaccination creates a kind of dependence on the medication.

The vaccine is difficult to create for this influenza type because flu virus is constantly changing and that is why you need a new vaccine every year. The flu shot is only effective against one particular strain of virus and this is why it needs to be re-administered every year.

Flu shots also contain toxic substances like mercury that is related to Alzheimer’s and may also lead to mercury poisoning. There is a law indemnifying vaccine manufacturers even if their vaccine ends up killing the patient.

Meningitis Vaccine Problem

2009-07-19T18:38:00.000-07:00

Glaxo Smith Kline (GSK) claims, the producers of meningitis vaccine (meningitis layer brain) for the Hajj, material from bovine (cow) and swine (pig) alias free animal was only sheer fabrication. GSK in the presentation in front of a number of institutions revealed that meningitis vaccine made still using the pig enzyme. This vaccination story actually have going on for long time but to overcome this problem need creativity of scientist to create for new kind of vaccine.

Kiai Umar asserted, because the enzyme has been in contact with pigs, MUI actually states that the status of the vaccine is haram (not allowed) to be use for Moslem.

For those reason MUI (Indonesian Moslem Association) decide the status of emergency for the meningitis vaccine. Section, he said, although the enzyme has been in contact with pigs, meningitis vaccine is required of Muslims to fulfill the Hajj and `Umrah to the Holy Land, Mecca.

For this condition, this is still open for meningitis vaccine producers of other types of meningitis can supply the needs of Indonesia of that vaccine, which needs very large amount annually. Not just Indonesia will need that vaccine but many other country also will use like, India, Iran, Turkey and Malaysia.

For every pilgrimage conditions should have meningitis vaccination, as they can go enter to Arab country. If they don’t use a meningitis vaccines, they will obligate to enter this country.

Influenza Vaccine

2009-06-30T00:22:00.000-07:00

Even many country efforts to build a vaccine for these diseases, but the result still don’t satisfied enough. Normal influenza as we known is not dangerous diseases, but after many changes on the virus character, this diseases become dangerous because of many new strain merge, like bird flu, swine flu and maybe will merge any other stronger kind of flu and can cause dead.

Flu become pandemic is always happen in many countries, but normally that is usual flue or influenza. Influenza normally can not cause dead for people, usually people just feel dizzy or headache, fever and make our body feel weak. But swine flu not just week but also high fever with high body temperature and cause unconsciousness and dead.

Tremendous efforts have been made by the vaccine industry to contribute to global preparedness plans for an influenza pandemic. The Influenza Vaccine Supply (IVS) International Task Force of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents 16 research-based vaccine manufacturers from around the world and works closely together with international stakeholders to address the advocacy, communication, policymaking, regulatory, scientific and technical issues related to seasonal and pandemic influenza vaccines. 11:35 Vaccines and Immunotherapeutics Against Influenza.

World Health Organization estimates that epidemic of influenza infects around 5-15% of the global population annually, and is responsible for up to 3-5 million cases of severe disease and 500,000 deaths per year. In the United States alone, over 35,000 deaths per year are attributed due to complications arising from influenza viral infections, particularly in the older adult population.

Vaccination Story

2009-05-13T18:27:00.000-07:00

More children in low-income households are receiving childhood vaccinations on schedule than in previous years, but disparities based on economic status remain, according to a new report.

Measles resurgence in 1989 to 1991 was partially attributed to low vaccination rates among low-income children, according to background information in the article. In response, government officials aimed to address disparities in vaccination coverage. In October 1994, the Vaccines for Children Program was established to eliminate cost barriers and provide publicly purchased vaccines at no cost to eligible children. "An important conclusion of Centers for Disease Control and Prevention [CDC] research conducted during the U.S. measles resurgence was that vaccines need to be administered on time because delays indicate inadequate protection against vaccine-preventable diseases," the authors write.

To assess progress since the establishment of the program, Philip J. Smith, Ph.D., and colleagues at the CDC, Atlanta, analyzed data from 232,318 children in low-income households (annual income of 133 percent or less of the federal poverty level) who participated in the U.S. National Immunization Survey between 1995 and 2007. Those who had received the recommended doses of vaccinations against diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, Haemophilus influenza type b, hepatitis B and varicella by age 19 months were categorized as having timely vaccination coverage. Coverage rates were compared with those of children in high-income households (400 percent or more of the federal poverty level) and changes were tracked over time for children born each year between 1994 and 2004.

"In our analyses, we found that among low-income children, timely vaccination coverage rates for all vaccines except Hib [Haemophilus influenza type b] have increased significantly between consecutive cohorts born after the measles resurgence," the authors write. For low-income children born between 1994 and 2004, timely coverage increased each year by 5.3 percent for varicella vaccines, 1.2 percent for hepatitis B, 0.6 percent for measles, mumps and rubella (MMR), 0.5 percent for the diphtheria, tetanus and pertussis (DTaP-DTP) vaccine and 0.3 percent for polio.

"Also, significant disparities in timely vaccination coverage were found between low- and high-income children for all childhood vaccines and nearly every birth cohort born between 1994 and 2004," the authors write. "However, these disparities have been declining significantly for the MMR [an estimated 0.3 percent decline], hepatitis B [0.3 percent] and varicella [0.5 percent] vaccines." In contrast, disparities increased significantly by 0.4 percent for the DTaP-DTP vaccine and did not change for polio.

The results suggest that progress has been made but that additional efforts are needed, the authors note. "Further progress in timely vaccination may be achieved by improving health care providers' reminder/recall systems, implementing educational interventions that address barriers to vaccination and increasing parents' awareness of the Vaccines for Children Program," they conclude.

How Does The Body Defend Against Infection

2009-04-30T00:42:00.000-07:00

Suppose a pathogenic agent (an organism that is capable of causing an infection) does invade the body. The threat is that it will cause disease, either because it is present in great members (as in pneumonia) or because it can release toxins (as in botulism, TSS, tetanus, or diphtheria). What can the body to do fight off the pathogen?

The Outer Defenses
The skin and mucous membranes are the body’s first line of defense. An invading microbe must find its way through the skin or the mucosae, the mucus-coated membranes that make an “inner skin” for the body by lining the respiratory, digestive, and urogenital tracts. Here are also secretions, such as tears, perspiration, skin oils, and saliva, that contain chemicals that can kill bacteria. In addition the respiratory passages are lined with fine, short, moving hairs called cilia. Beating in synchronized fashion, the cilia move a carpet of sticky mucus. The mucus works like fly paper to trap inhaled microbes and foreign matter and carry them to back of the throat, where they are removed by sneezing, coughing, or nose-blowing, or are swallowed and disposed of by digestive fluids.

Besides the cilia, other body hairs (the eyelashes, for example) may fend off invading microorganisms. Our reflexes (coughing, blinking, vomiting) are also part of our body’s firs line of defense. High acid levels in the stomach and vagina also help destroy invaders.

Charting Immunity History

2009-04-18T22:33:00.000-07:00

We can prevent many communicable diseases through vaccination. And we may be immune to certain other diseases if we've actually had these diseases, they produce immunity for varying lengths of time their actions on our bodies.

What disease are you immune to? Look to communicable diseases listed below. Have effective vaccines been developed for all of them? Check those that have vaccines, then write vaccinated for it. You may need to consult your parents, your family physician, or some other source to obtain some of this information.

No.	Had the Diseases	Initial Vaccination	Most recent Vaccination	Length of time this Immunization will last
1. Ordinary ("red") Measles
2. German Measles
3. Mumps
4. Flu
5. Polio
6. Whooping cough

Immune mean in order to prevent a disease from spreading, scientist don't know far below 100% immunity we can go in our population without having new outbreaks of these diseases. So it's important for all of us to keep our own vaccinations up to date and to urge others to do the same. Check back to see when you last had your "shots" and find out when you should go for any further shots or booster.

Recommended Schedule for Active Immunization

Age (months)	Vaccines
2	Diphtheria-tetanus-pertussis (DTP), Oral polio vaccine
4	DTP, oral polio vaccine
6	Oral polio vaccine
15	Measles, rubella, mumps
18	DTP, oral polio booster
4 to 6 years (school entry)	DPT booster, oral polio booster
14 to 16 years	Combined tetanus and diphtheria toxoid, Adult type (repeat every 10 years)

Enzyme

2009-02-07T05:33:00.000-08:00

Various kinds of protein molecules known as enzymes serve to accelerate, or catalyze, the chemical reactions of living cells. Without enzymes, most biochemical reactions would proceed too slowly to effectively carry on life processes.

The manufacture of these enzymes is regulated by the cells genetic material, deoxyribonucleic acid (DNA), through the process of protein synthesis. The potential of a cell to grow and divide is determined largely by the number and different kinds of enzymes it contains. Certain cell also perform specialized functions, such as transmitting nerve impulses or producing hormones, that are regulated by enzymes or producing hormones, that are regulated by enzymes. Several hundred different reactions may catalyzed by one or more enzymes.

Enzymes differ from inorganic catalysts, such as platinum and palladium, in two important ways: the sequence of amino acids in an enzyme molecule is catalytic action, and each system exerts its catalytic action only on specific substances in specific reactions. A nonbiological catalyst, by contrast, catalyzes a wide variety of chemical reactions.

Antibody

2008-11-21T17:25:00.000-08:00

The definition of antibody are proteins in the blood that can combine with foreign substances (antigens) and assist in their removal from the body. The production of agens and is part of the immune response against pathogens and is important in recovery from the infectious diseases caused by bacteria or viruses.

The continued presence of antibody molecules in the blood after an infections is one reason for the long lasting Immunity to many diseases. Individual antibody molecules have a high affinity for one particular antigen, but the body produces millions of different antibodies.

Another defensive function of antibodies is the protection of the new born infant. The antibody received across the placenta from the mother protect the newborn until it has developed its own antibodies. Antibodies are also present in the mother's milk and can be absorbed during breast feeding. In many mammals this is the newborn's only antibody source.

Vaccine Preparation

2008-11-13T07:29:00.000-08:00

Shake vial vigorously to obtain a uniform suspension prior to withdrawing each dose. Whenever solution and container permit, inspect vaccine visually for particulate matter and/or discoloration prior to administration. If problems are noted (e.g., vaccine cannot be resuspended), the vaccine should not be administered.

Reconstitute just before using. Use only the diluents supplied with the vaccine. Inject the volume of the diluents shown on the diluents label into the vial of lyophilized vaccine and gently agitate to mix thoroughly. Withdraw the entire contents and administer immediately after reconstitution.

Discard single dose MPSV4, varicella, and zoster vaccines if not used within 30 minutes after reconstitution.

Note: Unused reconstituted MMR vaccine and multidose MPSV4 vaccine may be stored at 35–46°F (2–8°C) for a limited time. The reconstituted MPSV4 vaccine must be used within 35 days; the reconstituted MMR vaccine must be used within 8 hours. Do not freeze either reconstituted vaccine.

Always refer to the package insert included with each biologic for complete vaccine administration information. CDC's Advisory Committee on Immunization. Practices (ACIP) recommendations for the particular vaccine should be reviewed as well.

Vaccine Injury Compensation Program (VICP)

2008-11-03T05:25:00.000-08:00

The VICP is a no-fault alternative to the traditional tort system for resolving vaccine injury claims. It was established as part of the National Childhood Vaccine Injury Act of 1986, after a rash of lawsuits against vaccine manufacturers and healthcare providers threatened to cause vaccine shortages and reduce vaccination rates.

The VICP covers all vaccines recommended by the Centers for Disease Control and Prevention for routine administration to children. It is administered jointly by the U.S. Department of Health and Human Services (HHS), the U.S. Court of Federal Claims (the Court), and the U.S. Department of Justice (DOJ). The VICP is located in the HRSA Healthcare Systems Bureau. Covered vaccines and compensible injuries are described on the “Vaccine Injury Table.”

The Claims Process

An individual claiming a vaccine-related injury or death files a petition for compensation with the Court, and may be represented by an attorney. The Secretary of HHS is named as the Respondent.

An HHS physician reviews the petition to determine whether it meets the medical criteria for compensation. This recommendation is provided to the Court through a Respondent's report filed by the DOJ. The HHS position is presented by an attorney from the DOJ in hearings before a "special master," who makes the decision for compensation under the VICP. A decision may be appealed to the Court, then to the Federal Circuit Court of Appeals, and eventually to the U.S. Supreme Court.

If a case is found eligible for compensation, the amount of the award is usually negotiated between the DOJ and the petitioner's attorneys. If the attorneys can't agree, the case is scheduled for a hearing for the special master to assess the amount of compensation.

Compensable claims, and even most claims found to be non-compensable, are awarded reimbursement for attorney's fees and costs. A petitioner may file a claim in civil court against the vaccine company and/or the vaccine administrator only after first filing a claim under the VICP and then rejecting the decision of the Court.

FUNCTIONS OF THE IMMUNE SYSTEM

2008-10-22T07:17:00.000-07:00

Under normal circumstances the immune system responds to foreign organism by production of antibodies and the stimulation of antigen-specific lymphocytes, leading to killing of the organism and neutralization of their toxic product (toxins). A major function of the immune system is surveillance of the cells of the body to ensure that they are not abnormal. Cell infected with viruses, malignant cell, or cells from another individual of the same species have protein markers on their outer membrane that act as a signal to the immune system to destroy them. The system to which these proteins belong is called the major histocompatibility complex (MHC) .

Immune responses are not always beneficial. They can contribute directly to pathological processes during infections and autoimmunity. The term hypersensitive or allergy are used when immune reaction produce tissue damage and harm the host; such reactions to an other wise harmless foreign substances may have severe effect and even lead to anaphylactic shock and death. In some cases for reasons that are not clear, normal cell may be wrongly identified as foreign or abnormal.

The immune system may develop antibodies and activate lymphocytes against them, producing autoimmune disease including systemic Lupus erythematosus, Myasthenia Gravis, diabetes and graves’ disease. Immune system also can develop by giving a vaccine to human or to animals.

Immunology

2008-10-20T07:57:00.001-07:00

The term immunity indicates the condition of an individual who recovers form a disease and is no longer susceptible to that disease a broader definition of immunity all of the physiological mechanism that give an organism the ability to recognize foreign substances and neutralize or degrade them, with or without injury to the organism’s own tissue. Immunology is branch of medicined concerned with the body’s response to foreign substances.

History of Immunology

In attempt to prevent diseases, 15^th- century Chinese practiced the custom inhaling dried powders of smallpox crusts to gain protection, but the inoculation of human smallpox materials was found to be hazardous. Edward Jenner observed that people who cought cowpox rarely contracted smallpox . In 1796 he induced cowpox in a young boy and later tried to infect the boy with smallpox, but the immunity provoked by the cowpox virus was effective against smallpox.

Louis Pasteur discovered in 1879 that neglected cultures of the bacteria that cause chickens chlorella lost much of their ability to cause the disease, whereas fresh cultures failed to infect chicken previously inoculated with old cultures. The introduction of dead or attenuated (weakened) microbes into the body to develop resistance to disease is called Vaccination (from the latin vacca; cow). Vaccination is used against such bacterial disease as cholera, dhphteria, and tetanus, and viral infection including hepatitis B, measles, polymielitis and rabies.

The work of Jenner and Pasteur marked the beginning of the field of immunology. Paul Ehrlich proposed the humoral theory of immunity, emphasizing the role of antibodies, protein produced by cells and released into the bloodstream, as the major agents of immunity. Russian biologist Elie Metchnikoff (1845-1946) developed the body’s scavenger cells, are the major detectors of foreign material and the primary defense system against infectious organisms. Both theory are correct.

Vaccination

2008-10-15T06:57:00.000-07:00

Vaccination is the inoculation of a person (or animal) in order to bring about immunity to an infection (pathogenic) organism. The term (from the Latin Vacca, “cow”) originally meant immunization against smallpox, because the procedure originated in 1796 the milkmaids who had contracted the mild disease cowpox (vaccinia) were immune to smallpox. The development of cowpox has since led to the production of vaccines against a wide range of diseases.

Vaccination is bases on the ability of a person’s immune system to respond much more effectively and rapidly to a microorganism the second or third time that the elements of the immune system encounter the invading organism. It was in this way, for example, that the milk maids immune system were “primed” by the cowpox virus to respond effectively to the closely related smallpox virus.

A vaccine may consist of living organisms that are weakened or attenuated, in a laboratory so that they create immunity but do not cause disease. It may also consist of related organisms that cause a similar but milder disease, of killed organisms, or of extracts of the organisms that can induce the desired immune response and subsequent immunity but do not cause the disease. Periodic booster immunization is recommended with most vaccines, because the immunity caused by the initial inoculation may decrease with time. The time interval before booster shots are required varies greatly with the type of vaccine.

Vaccination has occasional complications. Thus patients with a poorly functioning immune system have particular problems with certain vaccines. Immunodeficient patients may develop acute poliomyelitis from the attenuated virus vaccine, for example, although they do not develop the disease from killed polio virus. Transient problems with mild fevers, muscle aches, and tenderness at the inoculation site are also common to many vaccines. Control of serious disease by vaccination, however, is usually worth such risks.

Most of the exceptionally effective vaccines are viral vaccine, such as those for measles, mumps, and rubella. Influenza vaccines are recommended for individuals at high risk for serious infections of the lungs. Because influenza strains are different almost every year, vaccination should be carried out yearly in the susceptible population. Vaccination for yellow fever and certain types of hepatitis are also of proven efficacy. Also available are vaccines for certain bacterial infections, such as typhoid fever, cholera, diphtheria, whooping cough, and tetanus. Among new vaccines being developed are vaccines against malaria, leprosy, and dengue fever. Researchers are also exploring the production of multipurpose vaccines though genetic engineering using entitles such as the vaccinia virus or the bacterium known as BCG to carry genes from several disease organisms.

Vaccine Administration

2008-10-05T21:35:00.000-07:00

Vaccine administration includes all of this activity:

• Preparation
• Infection Control
• Vaccine preparation
• Administration

Each of that activity will describe more detail on the next articles, and must attention carefully on doing vaccine applications. Appropriate vaccine administration is critical to vaccine effectiveness. The recommended site, route and dosage for each vaccine are based on clinical trials, practical experience and theoretical considerations. The following information provides general guidelines for administration of vaccines for those who administer vaccines, as well as those in training, education and supervisory positions.

This information should be used in conjunction with professional standards for medication administration, vaccine manufacturers' product guidelines, CDC's Advisory Committee on Immunization Practices (ACIP) General Recommendations on Immunization, the American Academy of Pediatrics' (AAP) Report of the Committee on Infectious Diseases Red Book, and state/agency-related policies and procedures. An education plan that includes competency-based training on vaccine administration should be considered for all persons who administer vaccines to children or adults. All the vaccine activity for every diseases vaccine must follow the vaccine schedule that determine by the area conditions and current situation that sometime changes every time.

Vaccines Schedule

2008-09-26T22:18:00.000-07:00

1. Hepatitis B vaccine (HepB). (Minimum age: birth)

At birth:

Administer monovalent HepB to all newborns prior to hospital discharge.
If mother is hepatitis B surface antigen (HBsAg) positive, administer HepB and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth.
If mother’s HBsAg status is unknown, administer HepB within 12 hours of birth. Determine the HBsAg status as soon as possible and if HBsAg positive, administer HBIG (no later than age 1 week).
If mother is HBsAg negative, the birth dose can be delayed, in rare cases, with a provider’s order and a copy of the mother’s negative HBsAg laboratory report in the infant’s medical record. After the birth dose:
The HepB series should be completed with either monovalent HepB or a combination vaccine containing HepB. The second dose should be administered at age 1–2 months. The final dose should be administered no earlier than age 24 weeks. Infants born to HBsAg-positive mothers should be tested for HBsAg and antibody to HBsAg after completion of at least 3 doses of a licensed HepB series, at age 9–18 months (generally at the next well-child visit). 4-month dose:
It is permissible to administer 4 doses of HepB when combination vaccines are administered after the birth dose. If monovalent HepB is used for doses after the birth dose, a dose at age 4 months is not needed.

2. Rotavirus vaccine (Rota). (Minimum age: 6 weeks)

Administer the first dose at age 6–12 weeks.
Do not start the series later than age 12 weeks.
Administer the final dose in the series by age 32 weeks. Do not administer any dose later than age 32 weeks
Data on safety and efficacy outside of these age ranges are insufficient.

3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). (Minimum age: 6 weeks)

The fourth dose of DTaP may be administered as early as age 12 months, provided 6 months have elapsed since the third dose.
Administer the final dose in the series at age 4–6 years.

4. Haemophilus influenzae type b conjugate vaccine (Hib). (Minimum age: 6 weeks)

If PRP-OMP (PedvaxHIB® or ComVax® [Merck]) is administered at ages 2 and 4 months, a dose at age 6 months is not required.
TriHIBit® (DTaP/Hib) combination products should not be used for primary immunization but can be used as boosters following any Hib vaccine in children age 12 months or older.

5. Pneumococcal vaccine. (Minimum age: 6 weeks for pneumococcal conjugate vaccine [PCV]; 2 years for pneumococcal polysaccharide vaccine [PPV])

Administer one dose of PCV to all healthy children aged 24–59 months having any incomplete schedule.
Administer PPV to children aged 2 years and older with underlying medical conditions.

6. Influenza vaccine. (Minimum age: 6 months for trivalent inactivated influenza vaccine [TIV]; 2 years for live, attenuated influenza vaccine [LAIV])

Administer annually to children aged 6–59 months and to all eligible close contacts of children aged 0–59 months.
Administer annually to children 5 years of age and older with certain risk factors, to other persons (including household members) in close contact with persons in groups at higher risk, and to any child whose parents request vaccination.
For healthy persons (those who do not have underlying medical conditions that predispose them to influenza complications) ages 2–49 years, either LAIV or TIV may be used.
Children receiving TIV should receive 0.25 mL if age 6–35 months or 0.5 mL if age 3 years or older.
Administer 2 doses (separated by 4 weeks or longer) to children younger than 9 years who are receiving influenza vaccine for the first time or who were vaccinated for the first time last season but only received one dose.

7. Measles, mumps, and rubella vaccine (MMR). (Minimum age: 12 months)

Administer the second dose of MMR at age 4–6 years. MMR may be administeredbefore age 4–6 years, provided 4 weeks or more have elapsed since the first dose.

8. Varicella vaccine. (Minimum age: 12 months)

Administer second dose at age 4–6 years; may be administered 3 months or more after first dose.
Do not repeat second dose if administered 28 days or more after first dose.

9. Hepatitis A vaccine (HepA). (Minimum age: 12 months)

Administer to all children aged 1 year (i.e., aged 12–23 months). Administer the 2 doses in the series at least 6 months apart.
Children not fully vaccinated by age 2 years can be vaccinated at subsequent visits.
HepA is recommended for certain other groups of children, including in areas where vaccination programs target older children.

10. Meningococcal vaccine. (Minimum age: 2 years for meningococcal conjugate vaccine (MCV4) and for meningococcal polysaccharide vaccine (MPSV4))

Administer MCV4 to children aged 2–10 years with terminal complement deficiencies or anatomic or functional asplenia and certain other high-risk groups. MPSV4 is also acceptable.
Administer MCV4 to persons who received MPSV4 3 or more years previously and remain at increased risk for meningococcal disease.

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines, as of December 1, 2007, for children aged 0 through 6 years.

Vaccines

2008-09-19T06:22:00.001-07:00

Every baby who just bird need vaccine for their antibody building. Their antibody will against of similar diseases that try to enter to the body of the baby. Vaccine for human is begin just the baby is born.

The first Vaccine needed baby are:

Hepatitis
Tuberculoses
Diphtheria, polio and tetanus
Zoster
Varicella

Those are the minimum vaccine is needed for your children, from the beginning of bird till your baby age about 1 years old, and then will repeated for some vaccine not all vaccines such as BCG. For more detail about this vaccination, follow these article regularly.